Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Jul 01, 2021 11:14am
123 Views
Post# 33479113

RE:shares owned by management

RE:shares owned by managementSnowball - this is likely typical for this crew.
Slow and steady.
I'd guess they're not risk-takers (in general) so individual stocks aren't really their thing.

Goodman has 24 million shares, options and PSUs ... mostly in common shares.
Samira, Arvid and Amal are on a regular company purchase plan and will accumulate over time.

Arvid has 280K in mostly options - with 8,400 of it in common. 
Don't forget he's fairly new.

Amal has 650K in mostly options - with 118K of that in common. 
She was here with Goodman since Day-1.

Samira has 790K in mostly options - with 54K of it in common.  She came after Amal ... during the Jeffery Kandanoff shuffle. I think he's managing a family trust ... last I heard.

That's the core of the team for the first 6 years. 
Now we're up from 5 peole to about 700 - will see how that Top Team morphs.

----------------

Hope that helps.


<< Previous
Bullboard Posts
Next >>